Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 30
Filtrar
1.
Disabil Rehabil ; 44(26): 8222-8233, 2022 12.
Artigo em Inglês | MEDLINE | ID: mdl-34982599

RESUMO

PURPOSE: We summarized the effectiveness of home-based active video game interventions on physical and cognitive functions, as well as quality of life in adults with Parkinson's disease. We also assessed the feasibility, safety, adherence, and retention of benefits of these interventions. METHOD: We searched studies in eight databases from 1st March to 30th November 2020. Two authors independently performed the selection, data extraction and risk of bias evaluation (PROSPERO ID: CRD42020178138). RESULTS: Nine studies were included in this systematic review (412 participants). All in all, home-based active video games were found effective in improving gait and balance functions in people with Parkinson's disease, equivalent to usual care and conventional therapy. No conclusion can be drawn on cognition and quality of life. Home-based active video games seemed feasible, safe, and were enjoyed by people with Parkinson's disease. The optimal dose, the need for supervision and the retention of benefits of these interventions are still to be determined. These results should be interpreted carefully, considering the limited number of included studies and their small sample sizes, the widespread heterogeneity of included studies and their medium average methodological quality. CONCLUSION: Future research should focus on the effects of home-based active video games on impairments specific to Parkinson's disease, such as falls, freezing of gait and attention, as well as the dose, need for supervision and retention of the benefits of these interventions.IMPLICATIONS FOR REHABILITATIONHome-based active video games are effective in improving motor functions in people with PD.No conclusion can be drawn regarding cognition in people with PD.No conclusion can be drawn regarding quality of life in people with PD.Home-based active video games seem feasible and safe, and are enjoyed by people with PD.The dose, need for control and retention of the benefits still need to be determined.


Assuntos
Transtornos Neurológicos da Marcha , Doença de Parkinson , Jogos de Vídeo , Humanos , Doença de Parkinson/reabilitação , Qualidade de Vida , Transtornos Neurológicos da Marcha/reabilitação , Cognição
2.
Rev Neurol (Paris) ; 173(1-2): 55-61, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-28159316

RESUMO

INTRODUCTION: In the absence of specific clinical signs, imaging or biomarkers, the differential diagnosis of degenerative parkinsonian syndromes may be difficult at early stages of the disease. To reduce the risk of misdiagnosis or delayed diagnosis and referral to multiple medical centers at disease onset, easier access to expert centers should be available. To improve the initial care of parkinsonian patients, the Parkinson's disease Expert Center (PEC) at Pitié-Salpêtrière Academic Hospital has set up a specific outpatients clinic with short waiting times dedicated to the diagnosis of early Parkinson's disease and related disorders. METHODS: The PEC setup first identifies requests for diagnostic confirmation of parkinsonian syndromes, then specific outpatients clinic visits are scheduled weekly, with examinations carried out by neurologists at the PEC on a rotating schedule. Data from the first year of the new procedure were analyzed retrospectively through self-administered questionnaires sent to patients seen during this period. The main outcomes were to confirm the ability to keep to short delays for patients' examinations and to assess patients' satisfaction with the setup. RESULTS: Both study outcomes were achieved. The creation of an outpatients clinic dedicated to the early diagnosis of parkinsonian syndromes allowed shorter delays before the first examination of 5 weeks instead of several months. Keeping to the weekly schedule and limited time taken for each visit was also achieved. Following this initial outpatients visit, diagnosis of a parkinsonian syndrome was clinically confirmed or further specified in 80% of cases. A survey of patients' satisfaction showed a rate of over 91% in terms of the timing and course of clinical examinations at our PEC. DISCUSSION/CONCLUSION: This study of our quality-improvement program for Parkinson's disease management has shown that specific consultations with shorter waiting times aiming to allow early specialized assessment of parkinsonian syndromes is beneficial for patients and reduces the risk of delayed diagnoses.


Assuntos
Instituições de Assistência Ambulatorial/normas , Transtornos Parkinsonianos/diagnóstico , Encaminhamento e Consulta , Adulto , Idoso , Idoso de 80 Anos ou mais , Diagnóstico Precoce , Feminino , França/epidemiologia , Humanos , Masculino , Pessoa de Meia-Idade , Pacientes Ambulatoriais , Transtornos Parkinsonianos/epidemiologia , Encaminhamento e Consulta/normas , Encaminhamento e Consulta/estatística & dados numéricos , Estudos Retrospectivos , Adulto Jovem
3.
Rev Neurol (Paris) ; 172(11): 696-702, 2016 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-27318613

RESUMO

INTRODUCTION: One of the objectives of the French expert centers for Parkinson's disease (NS-Park) network was to determine a consensus procedure for assessing cognitive function in patients with Parkinson's. This article presents this procedure and briefly describes the selected tests. METHODS: A group of 13 experts used the Delphi method for consensus building to define the overall structure and components of the assessment procedure. For inclusion in the battery, tests had to be validated in the French language, require little motor participation, have normative data and be recognized by the international community. Experimental tasks and tests requiring specific devices were excluded. RESULTS: Two possibilities were identified, depending on whether an abbreviated or comprehensive assessment of cognitive function was necessary. For an abbreviated assessment, the experts recommended the Montreal Cognitive Assessment (MoCA) as a screening test for cognitive impairment or dementia. For a comprehensive neuropsychological assessment, the experts recommended assessing global efficiency plus the five main cognitive domains (attention and working memory, executive function, episodic memory, visuospatial function and language) that may be impaired in Parkinson's disease, using two tests for each domain. DISCUSSION AND CONCLUSION: A common procedure for assessing cognitive function is now available across the French network dedicated to Parkinson's disease, and is recommended for both research and clinical practice. It will also help to promote standardization of the neuropsychological assessment of Parkinson's disease.


Assuntos
Transtornos Cognitivos/diagnóstico , Cognição/fisiologia , Testes Neuropsicológicos , Doença de Parkinson/fisiopatologia , Doença de Parkinson/psicologia , Transtornos Cognitivos/fisiopatologia , Transtornos Cognitivos/psicologia , Consenso , Técnica Delphi , Função Executiva , Prova Pericial , França , Humanos , Memória de Curto Prazo , Testes Neuropsicológicos/normas , Doença de Parkinson/diagnóstico
5.
Neurophysiol Clin ; 45(4-5): 371-88, 2015 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-26319759

RESUMO

Deep brain stimulation (DBS) of the subthalamic nucleus (STN) and internal globus pallidus (GPi) deep brain stimulation (DBS) provides an efficient treatment for the alleviation of motor signs in patients with Parkinson's disease. The effects of DBS on gait and balance disorders are less successful and may even lead to an aggravation of freezing of gait and imbalance. The identification of a substantia nigra pars reticulata (SNr)-mesencephalic locomotor region (MLR) network in the control of locomotion and postural control and of its dysfunction/lesion in PD patients with gait and balance disorders led to suggestion that DBS should be targeting the SNr and the pedunculopontine nucleus (part of the MLR) for PD patients with these disabling axial motor signs. However, the clinical results to date have been disappointing. In this review, we discuss the effects of DBS of these basal ganglia and brainstem structures on the neurophysiological parameters of gait and balance control in PD patients. Overall, the data suggest that both STN and GPi-DBS improve gait parameters and quiet standing postural control in PD patients, but have no effect or may even aggravate dynamic postural control, in particular with STN-DBS. Conversely, DBS of the SNr and PPN has no effect on gait parameters but improves anticipatory postural adjustments and gait postural control.


Assuntos
Estimulação Encefálica Profunda/métodos , Transtornos Neurológicos da Marcha/terapia , Globo Pálido/fisiopatologia , Doença de Parkinson/terapia , Parte Reticular da Substância Negra/fisiopatologia , Núcleo Tegmental Pedunculopontino/fisiopatologia , Equilíbrio Postural , Núcleo Subtalâmico/fisiopatologia , Idoso , Estimulação Encefálica Profunda/efeitos adversos , Transtornos Neurológicos da Marcha/etiologia , Humanos , Pessoa de Meia-Idade , Doença de Parkinson/complicações , Postura , Resultado do Tratamento
6.
Transl Psychiatry ; 1: e5, 2011 May 03.
Artigo em Inglês | MEDLINE | ID: mdl-22832400

RESUMO

Functional and connectivity changes in corticostriatal systems have been reported in the brains of patients with obsessive-compulsive disorder (OCD); however, the relationship between basal ganglia activity and OCD severity has never been adequately established. We recently showed that deep brain stimulation of the subthalamic nucleus (STN), a central basal ganglia nucleus, improves OCD. Here, single-unit subthalamic neuronal activity was analysed in 12 OCD patients, in relation to the severity of obsessions and compulsions and response to STN stimulation, and compared with that obtained in 12 patients with Parkinson's disease (PD). STN neurons in OCD patients had lower discharge frequency than those in PD patients, with a similar proportion of burst-type activity (69 vs 67%). Oscillatory activity was present in 46 and 68% of neurons in OCD and PD patients, respectively, predominantly in the low-frequency band (1-8 Hz). In OCD patients, the bursty and oscillatory subthalamic neuronal activity was mainly located in the associative-limbic part. Both OCD severity and clinical improvement following STN stimulation were related to the STN neuronal activity. In patients with the most severe OCD, STN neurons exhibited bursts with shorter duration and interburst interval, but higher intraburst frequency, and more oscillations in the low-frequency bands. In patients with best clinical outcome with STN stimulation, STN neurons displayed higher mean discharge, burst and intraburst frequencies, and lower interburst interval. These findings are consistent with the hypothesis of a dysfunction in the associative-limbic subdivision of the basal ganglia circuitry in OCD's pathophysiology.


Assuntos
Gânglios da Base/fisiopatologia , Estimulação Encefálica Profunda/métodos , Neurônios/patologia , Transtorno Obsessivo-Compulsivo/fisiopatologia , Doença de Parkinson/fisiopatologia , Índice de Gravidade de Doença , Adulto , Gânglios da Base/patologia , Gânglios da Base/cirurgia , Estimulação Encefálica Profunda/instrumentação , Eletrodos Implantados , Humanos , Transtorno Obsessivo-Compulsivo/patologia , Transtorno Obsessivo-Compulsivo/terapia , Doença de Parkinson/patologia , Doença de Parkinson/terapia , Resultado do Tratamento
7.
Rev Neurol (Paris) ; 166(2): 188-95, 2010 Feb.
Artigo em Francês | MEDLINE | ID: mdl-19656539

RESUMO

The degenerative Parkinsonian "Plus" syndromes form a heterogeneous spectrum of pathologies comprising multiple system atrophy, progressive supranuclear palsy, Lewy body disease and cortico-basal degeneration. Their developmental profile is distinguished from that of Parkinson's disease by the early appearance of gait and balance disorders, isolated freezing of gait, primary progressive freezing of gait or an isolated or "pure" akinesia. The origin of these symptoms however remains poorly understood. The association of nigrostriatal dopamine neuron loss with either cortical lesions, in the case of cortico-basal degeneration and Lewy body disease, and/or of the brainstem, in the case of progressive supranuclear palsy, explains both the severity of the motor symptoms and the lack of, or minimal, improvement following levodopa therapy. Other symptomatic drug and surgical treatments have been proposed, but with generally disappointing results. Physiotherapeutic techniques targeting balance control can bring some temporary improvements.


Assuntos
Transtornos Neurológicos da Marcha/etiologia , Transtornos Parkinsonianos/fisiopatologia , Equilíbrio Postural/fisiologia , Progressão da Doença , Transtornos Neurológicos da Marcha/fisiopatologia , Gravitação , Humanos , Doença por Corpos de Lewy/etiologia , Doença por Corpos de Lewy/fisiopatologia , Atrofia de Múltiplos Sistemas/etiologia , Atrofia de Múltiplos Sistemas/fisiopatologia , Degeneração Neural/etiologia , Degeneração Neural/fisiopatologia , Transtornos Parkinsonianos/complicações , Transtornos de Sensação/etiologia , Transtornos de Sensação/fisiopatologia , Paralisia Supranuclear Progressiva/etiologia , Paralisia Supranuclear Progressiva/fisiopatologia , Caminhada/fisiologia
8.
Neurosci Lett ; 469(3): 400-4, 2010 Jan 29.
Artigo em Inglês | MEDLINE | ID: mdl-20026383

RESUMO

Human gait requires the simultaneous generation of goal-directed continuous movement (locomotion) and the maintenance of balance (postural control). In adults, the centre of mass (CoM) oscillates in the vertical plane while walking. During the single support phase of gait initiation, its vertical (vCoM) velocity increases as the CoM falls and is actively reversed prior to foot-contact. In this study we investigated whether this active control, which is thought to reflect balance control during gait initiation, is controlled by visual and somatosensory inputs (Experiment 1) and whether it is modified by a change in motor demands, two steps versus one step (Experiment 2). In all healthy adults, the vCoM velocity was braked, or controlled, by contraction of the soleus muscle of the stance leg. The elimination of visual input alone had no effect on braking, although its amplitude decreased when somatosensory inputs were disrupted (-47%), and further decreased when both visual and somatosensory inputs were disrupted (-83%). When subjects performed only one step, with no trailing of the stance foot, the vCoM velocity braking also decreased (-42%). These results suggest that active braking of the CoM fall during the transition to double support, an indicator of balance control, is influenced by both multisensory integration and the demands of the current motor program. The neural structures involved in this mechanism remain to be elucidated.


Assuntos
Equilíbrio Postural/fisiologia , Propriocepção/fisiologia , Desempenho Psicomotor/fisiologia , Percepção Visual/fisiologia , Caminhada/fisiologia , Adulto , Fenômenos Biomecânicos , Eletromiografia , Feminino , Pé/fisiologia , Marcha/fisiologia , Humanos , Perna (Membro)/fisiologia , Masculino , Músculo Esquelético/fisiologia , Estimulação Luminosa , Estimulação Física
9.
Brain ; 132(Pt 1): 172-84, 2009 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-19001482

RESUMO

The physiopathology of gait and balance disorders in Parkinson's disease patients is still poorly understood. Levodopa treatment and subthalamic nucleus (STN) stimulation improve step length and walking speed, with less effect on postural instability. These disorders have been linked to dysfunction of the descending basal ganglia outputs to brainstem structures. In this study, we evaluated the effects of stimulation of the substantia nigra pars reticulata (SNr), on locomotion and balance in Parkinson's disease patients. Biomechanical parameters and leg muscle activity were recorded during gait initiation in seven selected patients operated for bilateral STN stimulation, out of 204 stimulated patients, with one contact of each electrode located within the SNr. Step length, anteroposterior and vertical velocities of the centre of gravity were studied, with special reference to the subjects' ability to brake the centre of gravity fall before foot-contact, and compared to seven controls. In Parkinson's disease patients, five treatment conditions were tested: (i) no treatment, (ii) levodopa treatment, (iii) STN stimulation, (iv) SNr stimulation and (v) combined levodopa treatment and STN stimulation. The effects of these treatments on motor parkinsonian disability were assessed with the UPDRS III scale, separated into 'axial' (rising from chair, posture, postural stability and gait) and 'distal' scores. Whereas levodopa and/or STN stimulation improved 'axial' and 'distal' motor symptoms, SNr stimulation improved only the 'axial' symptoms. Compared to controls, untreated Parkinson's disease patients showed reduced step length and velocity, and poor braking just prior to foot-contact, with a decrease in both soleus (S) and anterior tibialis (AT) muscle activity. Step length and velocity significantly increased with levodopa treatment alone or in combination with STN stimulation in both natural and fast gait conditions, and with STN stimulation alone in the fast gait condition. Conversely, SNr stimulation had no significant effect on these measures in either condition. In the natural gait condition, no fall in the centre of gravity occurred as step length was low and active braking was unnecessary. In the fast gait condition, braking was improved with STN or SNr stimulation but not with levodopa treatment, with an increase in the stance leg S muscle activity. These results suggest that anteroposterior (length and velocity) and vertical (braking capacity) gait parameters are controlled by two distinct systems within the basal ganglia circuitry, representing respectively locomotion and balance. The SNr, a major basal ganglia output known to project to pontomesencephalic structures, is postulated as being particularly involved in balance control during gait.


Assuntos
Marcha , Doença de Parkinson/terapia , Equilíbrio Postural , Substância Negra/fisiopatologia , Idoso , Antiparkinsonianos/uso terapêutico , Terapia Combinada , Estimulação Encefálica Profunda/métodos , Avaliação da Deficiência , Eletromiografia/métodos , Feminino , Humanos , Perna (Membro)/fisiopatologia , Levodopa/uso terapêutico , Masculino , Pessoa de Meia-Idade , Músculo Esquelético/fisiopatologia , Doença de Parkinson/fisiopatologia , Resultado do Tratamento
10.
Rev Neurol (Paris) ; 165(1): 81-5, 2009 Jan.
Artigo em Francês | MEDLINE | ID: mdl-18808774

RESUMO

INTRODUCTION: Rest tremor, one of the main symptoms in Parkinson's disease (PD), is dramatically improved following subthalamic nucleus stimulation (STN). Results are often better than after l-dopa treatment. The occurrence of rest tremor after neurosurgery in patients without preoperative tremor is uncommon. AIM: The aim of this work was to investigate the role of subthalamic nucleus stimulation in the appearance of parkinsonian rest tremor. PATIENTS-RESULTS: Thirty PD patients (14%) out of 215 undergoing STN deep brain stimulation had an akinetorigid form of the disease, without preoperative tremor 11 years after onset of the disease. Six of them experienced the appearance of tremor six months after bilateral STN stimulation when the stimulator was switched off in the Off medication state. This de novo parkinsonian tremor was improved by l-dopa treatment and disappeared when the stimulator was turned on. CONCLUSION: This finding suggests that infraclinical parkinsonian tremor is probably present in all PD patients.


Assuntos
Tumor de Resto Suprarrenal/diagnóstico , Estimulação Encefálica Profunda , Doença de Parkinson/diagnóstico , Núcleo Subtalâmico/fisiologia , Antiparkinsonianos/uso terapêutico , Feminino , Humanos , Levodopa/uso terapêutico , Masculino , Pessoa de Meia-Idade , Rigidez Muscular/etiologia , Procedimentos Neurocirúrgicos , Tremor/etiologia
11.
Rev Neurol (Paris) ; 164(1): 53-60, 2008 Jan.
Artigo em Francês | MEDLINE | ID: mdl-18342058

RESUMO

Three characteristic observations are presented along with three tables presenting 24 patients with the following elements in common: excessively repeated use of an instrument such as a pen, a musical instrument or a tool. The appearance after that use of a central pathological phenomenon that includes a local dystonia of a hand or the mouth, a tremor, or the association of a tremor and a dystonia, all within the muscular domain corresponding to that of the use. The discussion, which is based exclusively on the clinical findings, deals with the following elements: the role of the use of the instrument rather than task itself, the predominant pathogenic factor which is the repetitive action, to which is added a genetic component in one incompletely penetrant case of DYT 1, and a probable genetic susceptibility in the others. The absence of improvement with rest distinguishes this central pathology from rheumatologic or orthopaedic problems involving repetitive activities. The evolution is slowly declining when the responsible action is continued. This occurs in three stages: a specific disorder involving only the use of the particular instrument, a more enlarged involvement affecting other activities and eventually a dystonia associated with a tremor or a postural tremor always located to the initial area. The therapeutic interventions suggested by the pathologic role of the repetitive movement is: (1) to advise a new training for the instrument that excludes the habitual movement; (2) to advise the patient to vary any newly acquired repetitive movements.


Assuntos
Transtornos Traumáticos Cumulativos/complicações , Distonia/etiologia , Tremor/etiologia , Adulto , Idoso , Transtornos Traumáticos Cumulativos/fisiopatologia , Transtornos Traumáticos Cumulativos/prevenção & controle , Distonia/prevenção & controle , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Música , Educação de Pacientes como Assunto , Tremor/prevenção & controle
12.
Rev Neurol (Paris) ; 163(3): 375-86, 2007 Mar.
Artigo em Francês | MEDLINE | ID: mdl-17404527

RESUMO

Tourette's syndrome is a neuropsychiatric disorder characterised by both involuntary movements, tics, and psychiatric symptoms, attentional deficit disorder, hyperactivity, obsessive compulsive symptoms..., and can be the cause of major disability. Over the past 30 years, several types of treatment have been proposed for the treatment of tics in Tourette's Syndrome, ranging from psychotherapeutic approaches to neurosurgery. The education of the patient and his entourage is fundamental and must be offered to all patients. Psychotherapy does not directly improve the tics but contributes to a better adjustment of both patient and carers to his disability. The decision to start a course of drug therapy depends largely on the impact of the patient's tics on his personal life. Drug treatment relies on neuromodulators acting on a variety of neural systems and whose efficacy has been rarely demonstrated. The literature shows that the latest generation of dopaminergic antagonists have the highest benefit/risk ratio. Recently, deep brain stimulation, by modulating neuronal activity in structures involved in the pathophysiology of the disease, has become a promising therapeutical approach, producing a marked decrease in the severity of tics over that obtained with other treatments.


Assuntos
Síndrome de Tourette/terapia , Antidepressivos/uso terapêutico , Antagonistas de Dopamina/uso terapêutico , Humanos , Procedimentos Neurocirúrgicos , Psicoterapia , Síndrome de Tourette/psicologia , Síndrome de Tourette/cirurgia
13.
J Neurophysiol ; 97(6): 4017-22, 2007 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-17460099

RESUMO

High-frequency stimulation of the subthalamic nucleus (STN) is an effective treatment for severe forms of Parkinson's disease (PD). To study the effects of high-frequency STN stimulation on one of the main output pathways of the basal ganglia, single-unit recordings of the neuronal activity of the substantia nigra pars reticulata (SNr) were performed before, during, and after the application of STN electrical stimulation in eight PD patients. During STN stimulation at 14 Hz, no change in either the mean firing rate or the discharge pattern of SNr neurons was observed. STN stimulation at 140 Hz decreased the mean firing rate by 64% and the mean duration of bursting mode activity of SNr neurons by 70%. The SNr residual neuronal activity during 140-Hz STN stimulation was driven by the STN stimulation. How the decrease in rate and modification of firing pattern of SNr-evoked neural activity, during high-frequency STN stimulation, contribute to the improvement of parkinsonian motor disability remains to be elucidated.


Assuntos
Estimulação Encefálica Profunda/métodos , Neurônios/efeitos da radiação , Doença de Parkinson/terapia , Substância Negra/patologia , Núcleo Subtalâmico/efeitos da radiação , Potenciais de Ação/fisiologia , Potenciais de Ação/efeitos da radiação , Idoso , Relação Dose-Resposta à Radiação , Estimulação Elétrica/métodos , Humanos , Pessoa de Meia-Idade , Neurônios/fisiologia , Doença de Parkinson/patologia , Doença de Parkinson/fisiopatologia
14.
Neurology ; 68(4): 267-71, 2007 Jan 23.
Artigo em Inglês | MEDLINE | ID: mdl-17151341

RESUMO

BACKGROUND: Stimulation of the subthalamic nucleus is an effective treatment for advanced Parkinson disease (PD) and is currently performed after a mean disease duration of 14 years, when severe motor complications have resulted in marked loss of quality of life. We examined whether surgery at an early stage would maintain quality of life as well as improve motor function. METHODS: Twenty patients with PD of short duration (time elapsed since first symptom +/- SD: 6.8 +/- 1.0 years) with mild to moderate motor signs (Unified Parkinson's Disease Rating Scale III "off" medication: 29 +/- 12) who responded well to levodopa treatment were included in pairs, matched for age, duration and severity of disease, and impairment in socioprofessional functioning. Patients were prospectively randomized to undergo bilateral subthalamic nucleus stimulation (n = 10) or receive optimized medical treatment (n = 10). Parkinsonian motor scores, quality of life, cognition, and psychiatric morbidity were assessed at inclusion and at 6, 12, and 18 months after randomization. RESULTS: Quality of life was improved by 24% in surgical and 0% in nonsurgical patients (p < 0.05). After 18 months, the severity of parkinsonian motor signs "off" medication, levodopa-induced motor complications, and daily levodopa dose were reduced by 69%, 83%, and 57% in operated patients and increased by 29%, 15%, and 12% in the group with medical treatment only (p < 0.001). Adverse events were mild or transient, and overall psychiatric morbidity and anxiety improved in the surgical group. CONCLUSIONS: Subthalamic nucleus stimulation should be considered a therapeutic option early in the course of Parkinson disease.


Assuntos
Procedimentos Neurocirúrgicos/métodos , Doença de Parkinson/terapia , Atividades Cotidianas/psicologia , Adulto , Antiparkinsonianos/uso terapêutico , Estimulação Encefálica Profunda , Feminino , Seguimentos , Humanos , Masculino , Pessoa de Meia-Idade , Doença de Parkinson/epidemiologia , Doença de Parkinson/psicologia , Estudos Prospectivos , Qualidade de Vida/psicologia , Núcleo Subtalâmico/fisiologia , Fatores de Tempo
15.
J Neural Transm Suppl ; (70): 409-14, 2006.
Artigo em Inglês | MEDLINE | ID: mdl-17017560

RESUMO

Despite the overall excellent outcome of neurosurgery in patients with Parkinson's disease, there is often a contrast between the improvement in motor disability and the difficulties of patients to reintegrate a normal life. In this study, the personal, familial and professional difficulties experienced by patients two years after bilateral high frequency stimulation of the subthalamic nucleus were carefully analyzed. To avoid such socio-familial maladjustment, we strongly suggest taking into consideration the patients' psychological and social context before the operation and during the post-operative follow-up.


Assuntos
Procedimentos Neurocirúrgicos , Doença de Parkinson/cirurgia , Estimulação Encefálica Profunda , Humanos , Pacientes , Médicos , Resultado do Tratamento
16.
J Neurol Neurosurg Psychiatry ; 77(11): 1223-8, 2006 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-16754693

RESUMO

BACKGROUND: Camptocormia is defined as an abnormal flexion of the trunk that appears when standing or walking and disappears in the supine position. The origin of the disorder is unknown, but it is usually attributed either to a primary or a secondary paravertebral muscle myopathy or a motor neurone disorder. Camptocormia is also observed in a minority of patients with parkinsonism. OBJECTIVE: To characterise the clinical and electrophysiological features of camptocormia and parkinsonian symptoms in patients with Parkinson's disease and camptocormia compared with patients with Parkinson's disease without camptocormia. METHODS: Patients with parkinsonism and camptocormia (excluding patients with multiple system atrophy) prospectively underwent a multidisciplinary clinical (neurological, neuropsychological, psychological, rheumatological) and neurophysiological (electromyogram, ocular movement recording) examination and were compared with age-matched patients with Parkinson's disease without camptocormia. RESULTS: The camptocormia developed after 8.5 (SD 5.3) years of parkinsonism, responded poorly to levodopa treatment (20%) and displayed features consistent with axial dystonia. Patients with camptocormia were characterised by prominent levodopa-unresponsive axial symptoms (ie, axial rigidity, gait disorder and postural instability), along with a tendency for greater error in the antisaccade paradigm. CONCLUSION: We suggest that (1) the salient features of parkinsonism observed in patients with camptocormia are likely to represent a specific form of Parkinson's disease and camptocormia is an axial dystonia and (2) both camptocormia and parkinsonism in these patients might result from additional, non-dopaminergic neuronal dysfunction in the basal ganglia.


Assuntos
Distonia/etiologia , Doença de Parkinson/complicações , Doença de Parkinson/fisiopatologia , Postura , Idoso , Gânglios da Base/fisiopatologia , Distonia/fisiopatologia , Eletromiografia , Eletrofisiologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Músculo Esquelético/patologia , Estudos Prospectivos , Caminhada
17.
Neurology ; 66(12): 1811-6, 2006 Jun 27.
Artigo em Inglês | MEDLINE | ID: mdl-16801642

RESUMO

OBJECTIVE: To prospectively evaluate the impact of subthalamic nucleus (STN) stimulation on social adjustment in patients with Parkinson disease (PD). METHODS: Before and 18 to 24 months after bilateral STN stimulation, the authors assessed 29 patients with PD for motor disability, cognition (Mattis dementia rating scale, frontal score), psychiatric morbidity (Mini-5.0.0, MADRS, BAS), quality of life (PDQ-39), social adjustment (Social Adjustment Scale), and psychological status using unstructured in-depth interviews. RESULTS: Despite marked improvement in parkinsonian motor disability, the absence of significant changes in cognitive status, and improvement of activities of daily living and quality of life by the end of the study, social adjustment did not improve. Several kinds of problems with social adjustment were observed, affecting the patients' perception of themselves and their body, marital situation, and professional life. Marital conflicts occurred in 17/24 couples. Only 9 out of 16 patients who had a professional activity before the operation went back to work after surgery. CONCLUSION: After STN stimulation, patients experienced difficulties in their relations with themselves, their spouses, their families, and their socio-professional environment. The authors suggest a multidisciplinary psychosocial preparation and follow-up to help patients and their entourage cope with the sudden changes in their existence following successful neurosurgery.


Assuntos
Transtornos Cognitivos/epidemiologia , Estimulação Encefálica Profunda/estatística & dados numéricos , Avaliação de Resultados em Cuidados de Saúde , Doença de Parkinson/epidemiologia , Doença de Parkinson/terapia , Qualidade de Vida , Ajustamento Social , Transtornos Cognitivos/diagnóstico , Transtornos Cognitivos/psicologia , Feminino , Humanos , Incidência , Masculino , Pessoa de Meia-Idade , Neurocirurgia/estatística & dados numéricos , Procedimentos Neurocirúrgicos/estatística & dados numéricos , Doença de Parkinson/diagnóstico , Doença de Parkinson/psicologia , Prognóstico , Medição de Risco/métodos , Fatores de Risco , Núcleo Subtalâmico , Suíça/epidemiologia , Resultado do Tratamento
18.
J Neurol Neurosurg Psychiatry ; 77(4): 443-9, 2006 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-16543519

RESUMO

BACKGROUND: High frequency stimulation of the subthalamic nucleus (STN) is an alternative but expensive neurosurgical treatment for parkinsonian patients with levodopa induced motor complications. OBJECTIVE: To assess the safety, clinical effects, quality of life, and economic cost of STN stimulation. METHODS: We conducted a prospective multicentre study in 95 consecutive Parkinson's disease (PD) patients receiving bilateral STN stimulation and assessed its effects over 12 months. A double blind randomised motor evaluation was carried out at 3 month follow up, and quality of life, self care ability, and predictive factors of outcome following surgery were assessed. The cost of PD was estimated over 6 months before and after surgery. RESULTS: The Unified Parkinson's Disease Rating Scale (UPDRS) motor score improved by 57% (p<0.0001) and activities of daily living improved by 48% (p<0.0001) at 12 month follow up. Double blind motor scoring improved by 51% at 3 month follow up (p<0.0001). The total PD Quality of Life Questionnaire (PDQL-37) score improved by 28% (p<0.001). The better the preoperative motor score after a levodopa challenge, the better the outcome after STN stimulation. Five patients developed an intracerebral haematoma during electrode implantation with permanent after effects in two. The 6 month costs of PD decreased from 10,087 euros before surgery to 1673 euros after surgery (p<0.0001) mainly because of the decrease in medication. These savings allowed a return on the procedure investment, estimated at 36,904 euros over 2.2 years. CONCLUSIONS: STN stimulation has good outcomes with relatively low risk and little cost burden in PD patients with levodopa induced motor complications.


Assuntos
Estimulação Encefálica Profunda/economia , Lateralidade Funcional/fisiologia , Doença de Parkinson , Núcleo Subtalâmico/fisiologia , Atividades Cotidianas , Idoso , Antiparkinsonianos/economia , Antiparkinsonianos/uso terapêutico , Análise Custo-Benefício , Estimulação Encefálica Profunda/instrumentação , Feminino , Seguimentos , Humanos , Levodopa/economia , Levodopa/uso terapêutico , Masculino , Doença de Parkinson/economia , Doença de Parkinson/fisiopatologia , Doença de Parkinson/terapia , Estudos Prospectivos , Qualidade de Vida/psicologia , Inquéritos e Questionários , Resultado do Tratamento
19.
J Neurol Neurosurg Psychiatry ; 76(12): 1640-4, 2005 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-16291886

RESUMO

BACKGROUND: The short term benefits of bilateral stimulation of the subthalamic nucleus (STN) in patients with advanced levodopa responsive Parkinson's disease (PD) are well documented, but long term benefits are still uncertain. OBJECTIVES: This study provides a 5 year follow up of PD patients treated with stimulation of the STN. METHODS: Thirty seven consecutive patients with PD treated with bilateral STN stimulation were assessed prospectively 6, 24, and 60 months after neurosurgery. Parkinsonian motor disability was evaluated with and without levodopa treatment, with and without bilateral STN stimulation. Neuropsychological and mood assessments included the Mattis Dementia Rating Scale, the frontal score, and the Montgomery-Asberg Depression Rating Scale (MADRS). RESULTS: No severe peri- or immediate postoperative side effects were observed. Six patients died and one was lost to follow up. Five years after neurosurgery: (i) activity of daily living (Unified Parkinson Disease Rating Scale (UPDRS) II) was improved by stimulation of the STN by 40% ("off" drug) and 60% ("on" drug); (ii) parkinsonian motor disability (UPDRS III) was improved by 54% ("off" drug) and 73% ("on" drug); (iii) the severity of levodopa related motor complications was decreased by 67% and the levodopa daily doses were reduced by 58%. The MADRS was unchanged, but cognitive performance declined significantly. Persisting adverse effects included eyelid opening apraxia, weight gain, addiction to levodopa treatment, hypomania and disinhibition, depression, dysarthria, dyskinesias, and apathy. CONCLUSIONS: Despite moderate motor and cognitive decline, probably due to disease progression, the marked improvement in motor function observed postoperatively was sustained 5 years after neurosurgery.


Assuntos
Estimulação Encefálica Profunda , Doença de Parkinson/terapia , Núcleo Subtalâmico , Atividades Cotidianas , Idoso , Antiparkinsonianos/uso terapêutico , Transtornos Cognitivos/etiologia , Progressão da Doença , Feminino , Seguimentos , Humanos , Levodopa/uso terapêutico , Masculino , Pessoa de Meia-Idade , Transtornos das Habilidades Motoras , Resultado do Tratamento
20.
J Neurol Neurosurg Psychiatry ; 76(7): 992-5, 2005 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-15965209

RESUMO

In this prospective double blind randomised "N of 1" study, a patient with a severe form of Tourette's syndrome was treated with bilateral high frequency stimulation of the centromedian-parafascicular complex (Ce-Pf) of the thalamus, the internal part of the globus pallidus (GPi), or both. Stimulation of either target improved tic severity by 70%, markedly ameliorated coprolalia, and eliminated self injuries. Severe forms of Tourette's syndrome may benefit from stimulation of neuronal circuits within the basal ganglia, thus confirming the role of the dysfunction of limbic striato-pallido-thalamo-cortical systems in this disorder.


Assuntos
Terapia por Estimulação Elétrica , Globo Pálido/fisiopatologia , Núcleos Intralaminares do Tálamo/fisiopatologia , Síndrome de Tourette/terapia , Adulto , Dominância Cerebral/fisiologia , Eletrodos Implantados , Feminino , Seguimentos , Humanos , Exame Neurológico , Estudos Prospectivos , Comportamento Autodestrutivo/fisiopatologia , Comportamento Autodestrutivo/terapia , Transtornos do Comportamento Social/fisiopatologia , Transtornos do Comportamento Social/terapia , Síndrome de Tourette/fisiopatologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...